Details for New Drug Application (NDA): 202493
✉ Email this page to a colleague
The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Summary for 202493
Tradename: | CHLOROTHIAZIDE SODIUM |
Applicant: | Rk Pharma |
Ingredient: | chlorothiazide sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jun 18, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription